CFO
MESO

CVA Family Office’s Mesoblast MESO Stock Holding History

CVA Family Office’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$934 Sell
69
-61
-47% -$907 ﹤0.01% 1656
2026
Q1 		$2K Buy
+130
New +$2.17K ﹤0.01% 1529

Other funds holding MESO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
FFA
Fi3 Financial Advisors Indianapolis, Indiana $418M AUM 35.26% 1-Year Est. Return

CVA Family Office's MESO Position: Q2 2026 in Review

CVA Family Office reduced its Mesoblast (MESO) stake by 47% in Q2 2026, selling an estimated $907 and leaving 69 shares worth $934. The position accounts for ﹤0.01% of the portfolio, ranked #1656.

CVA Family Office first reported a position in MESO in Q1 2026 and has held it in 2 quarters since. The position peaked at $2K in Q1 2026. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

  • CVA Family Office held 69 shares of Mesoblast worth $934 as of Q2 2026.
  • CVA Family Office sold 61 Mesoblast shares in Q2 2026, an estimated $907.
  • Mesoblast made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1656 holding.
  • CVA Family Office first reported a position in Mesoblast in Q1 2026 and has held it in 2 quarters since.
  • CVA Family Office's Mesoblast position peaked at $2K in Q1 2026.
  • 72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.